BSE filing, NSE: AMANTA. Summary written from the filing by ALFA Finder's alert engine.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹163.19
- Market cap
- ₹633.7 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 43.2×Sector 46.5×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Other Announcement
Amanta Healthcare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Amanta Healthcare Promoter Selling (Off-Market)
Pravinchandra Dhanjibhai Mehta, a promoter group member of Amanta Healthcare, disposed of 17,32,763 equity shares via an off-market gift. His stake decreased from 4.72% to 0.26%.
Amanta Healthcare Promoter Selling (Off-Market): ₹2.86 Cr
Promoter Pravinchandra Mehta sold 1,50,400 shares of Amanta Healthcare to fellow promoter Kirit Desai in an off-market inter-se transfer valued at ₹2.86 Crore.
- Value
- ₹2.86 Cr
Amanta Healthcare Promoter Buying (Off-Market): ₹2.86 Cr
Amanta Healthcare reported an inter-se off-market transfer of 1,50,400 equity shares between promoter group members. Kirit Ambalal Desai acquired the stake valued at ₹2.86 Crore from Pravinchandra Dhanjibhai Mehta.
- Value
- ₹2.86 Cr
- Promoter stake change
- +0.39%
Amanta Healthcare Promoter Buying (Off-Market): ₹5.72 Cr
Pravinchandra Dhanjibhai Mehta and Kirit Ambalal Desai, members of the promoter group, acquired 1,50,400 shares each via off-market inter-se transfers. Both transactions were valued at Rs. 2.86 Crore each.
- Value
- ₹5.72 Cr
- Promoter stake change
- +0.39%
Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.